Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure-Reference-Cited by-同舟云学术

Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure

Published:2013-04 Issue:4 Volume:61 Page:267-274
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Matsuzaki Masunori,Yamamoto Kazuhiro,Yano Masafumi,Nakamura Koki,Miyata Yuko,Sugiura Kenkichi,Nakata Emi,Tsutsui Hiroyuki

Funder

Takeda Pharmaceutical Company Limited

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

2. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

3. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: first report from the CHART-2 study;Shiba;Circ J,2011

4. mhlw.go.jp [Internet]. Trends in leading causes of death [updated 2011 September 1; cited 2011 September 29]. Tokyo: Ministry of Health, Labour and Welfare. Available from: http://www.mhlw.go.jp/english/database/db-hw/populate/dl/03.pdf [accessed July 3, 2012].

5. Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans;Vauquelin;J Hypertens Suppl,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients;Journal of Cardiology;2014-03

2. Angiotensin II receptor blockers for patients with chronic heart failure: The next step forward;Journal of Cardiology;2013-04